私募6月调研青睐电子和医药迈威生物获调研超50次

投资快报2025-07-04

投资快报记者从私募排排网最新数据显示，6月共有751家私募证券管理人参与A股上市公司调研，覆盖28个申万一级行业中的387只个股，合计调研次数达1769次。从调研热度来看，6月共有46只个股获得私募机构的高度关注，调研频次均不少于10次。具体来看，32只个股被调研10-19次，14只个股调研频次不少于20次。迈威生物6月获得私募调研51次，成为最受私募调研青睐的个股，该股属于医药生物行业，吸引到...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2548017333?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-04 07:26","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2548017333","market":"sh","top_or_hot":-1,"title":"私募6月调研青睐电子和医药  迈威生物获调研超50次","media":"投资快报","content":"<div>\n<p>投资快报记者从私募排排网最新数据显示，6月共有751家私募证券管理人参与A股上市公司调研，覆盖28个申万一级行业中的387只个股，合计调研次数达1769次。从调研热度来看，6月共有46只个股获得私募机构的高度关注，调研频次均不少于10次。具体来看，32只个股被调研10-19次，14只个股调研频次不少于20次。迈威生物6月获得私募调研51次，成为最受私募调研青睐的个股，该股属于医药生物行业，吸引到...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704072908a72d75b9&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>私募6月调研青睐电子和医药  迈威生物获调研超50次</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n私募6月调研青睐电子和医药  迈威生物获调研超50次\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-04 07:26 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704072908a72d75b9&s=b><strong>投资快报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>投资快报记者从私募排排网最新数据显示，6月共有751家私募证券管理人参与A股上市公司调研，覆盖28个申万一级行业中的387只个股，合计调研次数达1769次。从调研热度来看，6月共有46只个股获得私募机构的高度关注，调研频次均不少于10次。具体来看，32只个股被调研10-19次，14只个股调研频次不少于20次。迈威生物6月获得私募调研51次，成为最受私募调研青睐的个股，该股属于医药生物行业，吸引到...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704072908a72d75b9&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704072908a72d75b9&s=b","article_id":"2548017333","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704072908a72d75b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2548017333","pubTimestamp":1751585168,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"迈威生物6月获得私募调研51次，成为最受私募调研青睐的个股，该股属于医药生物行业，吸引到高毅资产、海南希瓦、聚鸣投资、宁泉资产、盘京投资、中欧瑞博、重阳投资等百亿私募扎堆调研。正圆投资调研最为积极，6月调研35次居首。6月共有31家百亿私募参与到A股调研，合计调研达176次。其次是高毅资产、睿郡资产、和谐汇一资产、重阳投资、宁泉资产等10家百亿私募，6月调研次数均不少于5次。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159938":"医药","688062":"迈威生物","688506":"百利天恒","BK0239":"医药制造"},"translate_title":"Private equity survey in June favored electronics and medicine, Maiwei Biotech received more than 50 surveys","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1,"688062":1,"688506":0.9},"content_text":"投资快报记者从私募排排网最新数据显示，6月共有751家私募证券管理人参与A股上市公司调研，覆盖28个申万一级行业中的387只个股，合计调研次数达1769次。从调研热度来看，6月共有46只个股获得私募机构的高度关注，调研频次均不少于10次。具体来看，32只个股被调研10-19次，14只个股调研频次不少于20次。迈威生物6月获得私募调研51次，成为最受私募调研青睐的个股，该股属于医药生物行业，吸引到高毅资产、海南希瓦、聚鸣投资、宁泉资产、盘京投资、中欧瑞博、重阳投资等百亿私募扎堆调研。另外1只医药生物行业个股百利天恒被调研29次入围前十，参与调研私募机构包括明汯投资、睿郡资产和中欧瑞博等百亿私募。电子和计算机行业均有2只个股入围前十，其中电子行业个股海光信息和计算机行业个股中科曙光均被调研39次并列第二。6月共有21个申万一级行业被私募机构调研不少于10次，其中11个行业被调研10-49次，4个行业被调研50-99次，更有6个行业调研次数突破100次大关。电子行业共有56只个股合计获得275次私募调研，成为最受私募调研青睐的行业。紧随其后的是医药生物行业，该行业中有41只个股获得私募机构合计调研达266次。其次是机械设备行业，该行业中有52只个股获得私募机构合计调研达234次。计算机行业则有36只个股获得私募机构合计调研达213次。此外，汽车和基础化工行业被调研次数均不少于100次，被调研个股数量均不少于25只。6月共有85家私募机构有积极参与A股调研，调研频次均不少于5次，其中62家调研5-9次，23家调研不少于10次。正圆投资调研最为积极，6月调研35次居首。百亿私募前十占二席，盘京投资和聚鸣投资2家百亿私募调研次数排名前十，6月分别调研19次和13次。6月共有31家百亿私募参与到A股调研，合计调研达176次。其中盘京投资、聚鸣投资、星石投资、淡水泉和敦和资管调研较为积极，6月调研次数均不少于10次。其次是高毅资产、睿郡资产、和谐汇一资产、重阳投资、宁泉资产等10家百亿私募，6月调研次数均不少于5次。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2548017333","isCrawlerRequest":true}

私募6月调研青睐电子和医药 迈威生物获调研超50次

精彩评论

私募6月调研青睐电子和医药迈威生物获调研超50次